ERIN DELANEY: Open Payments
NPI 1063811461 · NORWOOD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 10 payments from 4 companies in 2025. Trend: 2023 $350 · 2024 $194 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: REXULTI, CAPLYTA, Auvelity, Qelbree.
Industry payments across MA — which companies pay providers there.
